Rate My Professor Minyon Avent

Avent's research specializations include antimicrobial stewardship programs, pharmacokinetic and pharmacodynamic optimisation of antibiotics, and strategies to reduce antibiotic prescribing and resistance. She has authored over 50 peer-reviewed publications and conference papers, including 'Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network' (2024), 'Reducing antibiotic prescribing in general practice in Australia: a cluster randomised controlled trial of a multimodal intervention' (2023), 'Improving paediatric antimicrobial stewardship in remote and regional Queensland hospitals: development and qualitative evaluation of a tailored intervention for intravenous-to-oral antibiotic switching' (2022), 'Implementation of a novel antimicrobial stewardship strategy for rural facilities utilising telehealth' (2021), 'Where to from here? Identifying and prioritising future directions for addressing drug-resistant infection in Australia' (2021), 'Oral or intravenous antibiotics?' (2020), 'Fosfomycin: what was old is new again' (2018), and 'An underutilised resource for Antimicrobial Stewardship: a ‘snapshot’ of the community pharmacists’ role in delayed or ‘wait and see’ antibiotic prescribing' (2018). She has contributed to funded projects such as 'An innovative Antimicrobial Stewardship Program for children in remote and regional areas: optimising antibiotic use through early intravenous-to-oral conversion' (2018-2020, The Children's Hospital Foundation), 'Randomised controlled study of an intense short course of optimised combination therapy versus conventional therapy for the management of Gram-negative bacteraemia' (2014-2018, Merck Sharp & Dohme), and 'General Practitioner Antimicrobial Stewardship Programme Study (GAPS)' (2015-2016). Avent has presented her findings at national and international conferences, advancing antimicrobial stewardship practices across diverse healthcare contexts.